![Cocrystal Pharma, Inc. logo](/logos/COCP.webp)
Cocrystal Pharma, Inc.
NASDAQ:COCP
Overview | Financials
Company Name | Cocrystal Pharma, Inc. |
Symbol | COCP |
Currency | USD |
Price | 1.7 |
Market Cap | 17,295,460 |
Dividend Yield | 0% |
52-week-range | 1.33 - 3.1 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Sam Lee Ph.D. |
Website | https://www.cocrystalpharma.com |
An error occurred while fetching data.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD